MedPath
NMPA Approval

Digoxin Injection

国药准字H20234528

January 10, 2024

Drug Information

地高辛注射液

注射剂

2ml:0.5mg

化学药品

January 10, 2024

Company Information

Applicant Company

海南省海口市药谷一路6号海口国家高新区引领科技众创园B栋1层

Manufacturing Company

海口国家高新区药谷工业园二期内

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

地高辛注射液 - NMPA 批准文号 | MedPath